Star Imaging and Path Lab Limited
Bookbuilding IPO · BSE
- Price band
- ₹135 - ₹142
- Lot size
- 1,000 shares
- Issue amount
- ₹69.46 cr
- Total subscription
- 5.67×
- Opens
- 8 Aug 2025
- Closes
- 12 Aug 2025
- Allotment
- 13 Aug 2025
- Listing
- 18 Aug 2025
Offer at a glance
Issue overview
- Issue size
- 48,92,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,35,000
- Fresh issue
- ₹55.66 cr
- Offer for sale
- ₹13.8 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,42,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,35,00,000
- Shares after issue
- 1,74,20,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 2 | 2,000 | ₹2,84,000 |
| sHNI | 3 | 3,000 | ₹4,26,000 |
| bHNI | 8 | 8,000 | ₹11,36,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | 0 | 9 |
| NIB | 0 | 200 |
| RETAIL | 764 | 1,766 |
| EMPLOYEES | 0 | 5 |
| HNIs(10L +) | 146 | 257 |
| HNIs (2-10L) | 73 | 192 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 12.37 | 101.12 |
| RETAIL | 21.7 | 27.8 |
| HNIs 2+ | 3.11 | 4.67 |
| HNIs 10+ | 6.22 | 19.47 |
| EMPLOYEES | 0.74 | 0.18 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 11.79 | 9.14 | 0.42 |
| ROE | 0 | 0 | 0 |
| ROCE | 29.83 | 29.54 | 5.74 |
| RONW | 0 | 0 | 0 |
| PRE IPO(PE) | 12.01 | 0 | 0 |
| POST IPO(PE) | 15.5 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Star Imaging and Path Lab Limited, founded in 2004, is a healthcare company offering a wide range of diagnostic services, including radiology tests like X-rays, CT scans, MRIs, and ultrasounds, as well as pathology services such as blood tests, microbiology, PCR, and histopathology. With advanced equipment and skilled medical professionals, the company focuses on delivering accurate and timely results to support effective diagnosis and treatment. Operating across multiple regions, it serves both individual patients and healthcare institutions. As of September 30, 2024, the company employs 209 full-time staff, including executive directors.
Strengths
- All-in-one testing facility – provides both pathology and radiology services at a single location
- Strong industry reputation – well-known with a solid track record in healthcare diagnostics
- Skilled management team – led by experienced professionals with deep sector expertise
Risk factors
- Legal cases in progress – ongoing matters involving the company, promoters, and directors may affect business if outcomes are negative
- Missing financial reports – past non-filing of consolidated financials with RoC could raise regulatory issues
- CSR rules not followed – failure to meet CSR duties from FY 2021–22 to FY 2023–24 may lead to penalties
Promoters
Mr. Pawan Gupta
Registrar & documents
Lead manager
Share India Capital Services Private Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
4B/4, Tilak Nagar, Near Sant Pura, Tilak Nagar West Delhi, New Delhi, New Delhi, 110018
+91 9990019189
[email protected]Company website ↗Understanding STARIMAGIN IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.